Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. MPs told public may need to stockpile drugs in no-deal Brexit
  2. The People vs Big Pharma: tackling the industry’s trust issues
  3. AbbVie poised to overtake Gilead as hepatitis C leader
  4. The influence of coagulation cascade targets in CVD
  5. UK bioethics panel finds human genome editing ethically acceptable

Latest Content


Are you a manufacturer, importer, distributor or wholesaler of healthcare products? RAQAC has the specialised knowledge to help you navigate the Canadian regulatory requirements for registering and marketing products.

Welcome to DJA-Pharma

DJA-Pharma is a pharmaceutical solutions provider that proposes equipment and services to meet its clients' needs for growth.

Reducing the Costs of Speciality Pharmaceutical Shipments

The specialty pharmacy industry can reduce costs by $27.5 million annually (product and call centre staff costs only) if visual temperature indicators were used as decision-making tools to determine if medicine should be used or returned when patients suspect heat damage.

Fast and Reliable Quantification of Data

Omnian was developed for Malvern Panalytical's high-end x-ray fluorescence (XRD) spectrometer and is also available for the Epsilon 4 energy dispersive x-ray fluorescence (EDXRF) benchtop systems. This powerful combination brings together the strengths of Omnian with the ease-of-use of Epsilon 4.

Brexit backlash: EU cuts UK’s MHRA out of drug approval process

The European Medicines Agency (EMA) has cut the UK Medicines and Healthcare Products Regulatory Agency (MHRA) out of its drug approval process seven months earlier than expected in preparation for Brexit, according to media reports. The move will slash the MHRA’s annual budget by approximately €50m ($59M).

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top